Drug information on Forstal (1000 mg) (Ertapenem) from Zyphars Pharmaceuticals Pvt Ltd

Medical Condition(s) for which Forstal (1000 mg) may be prescribed

---

•  Local: Infused vein complication, pain, redness, extravasation(accidental administration of the drug in the surrounding tissues), inflammation or blood clot in veins, swelling, indurations, and warmth.

♦ •  Body as a whole: Abdominal distention, pain, chills, septicemia, septic shock, dehydration, gout, uneasiness, necrosis, candidiasis, weight loss, facial edema, flank pain, incoordination, muscle weakness, syncope and severe allergic reactions.

•  Heart: Chest pain, high or low blood pressure, fast heart rate.

•  Central Nervous System: Headache, altered mental status, sleeplessness, dizziness, anxiety, weakness/fatigue, seizure, movement disorder, hallucinations, tremor.

•  Skin: Diaper dermatitis (rash in the thighs and buttocks of infants), rash.

•  Eye and ENT: Inflammation and viral infection of nasopharynx.

•  Gastrointestinal: Diarrhea, vomiting, nausea, abdominal pain, constipation, acid regurgitation, inflammation and infection of the large intestine, small intestine obstruction, abdominal abscess.

•  Genitourinary: Urinary tract infection, vaginal inflammation.

•  Respiratory: Cough, difficulty in breathing, pneumonia, upper respiratory tract infection, respiratory distress.

•  Miscellaneous: Anemia, viral infections.

Adults: IV/IM- 1g/day for 7 to 14 days. Children: 15 mg/kg twice daily.

It is usually given as an injection at your doctor's office, hospital, or clinic.

Allergic to penicillins or cephalosporins, or local anesthetics.

• Long-term or repeated use of this medication may cause a second infection.

•Monitor kidney function, liver function, and complete blood cell counts while using this medication.

•Caution needed for pregnant women, children less than 3 months, and elderly.

Continue to use this medication until the full prescribed treatment period is finished.

It is usually handled and stored by a health care provider.

♦ Safety Labeling Changes Approved By FDA